DexCare

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://dexcare.com/

Last Round

Series C

Jun 21, 2023

Total Funding Raised

$145M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DexCare is a healthcare technology company that offers an access optimization platform to intelligently orchestrate health system capacity and digital demand across all lines of care.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

care orchestrationdigital front doorpatient navigationpatient accessscheduling optimizationelectronic health recordsEHRhealth techhealthcare SaaSsmall language modelsSLMAI schedulingprovider capacityhealthcare workflow automationpatient demand management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DexCare Comps

Public and private peers based on sector, stage, and business model.

DexCare comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DexCare Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Jun 21, 2023
Series B	Jan 13, 2022
Series A	Mar 22, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Matthew Blosl

Chief Executive Officer (CEO)

Executive Team

Chris Carruthers

VP Of Product, Chief Innovation Officer, VP Of Solutions

Executive Team

DexCare Investors

Notable investors and investment history

DexCare investors
Investor	Rounds
Define Ventures	Series C, Series B, Series A
Kaiser Permanente Ventures	Series C, Series A, Series B
Frist Cressey Ventures	Series A, Series B, Series C
ICONIQ Growth	Series C
Allumia Ventures	Series A, Series B
SpringRock Ventures	Series C, Series A, Series B
Define Ventures	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 28, 2026
Ravi Doddivaripalli joins as the new CTO.
Dec 15, 2025
Rakshay Jain joins as Chief Product Officer.

View all signals

DexCare Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DexCare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DexCare's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range135

Year Founded2021

Last FundingJun 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.